Vai al contenuto principale della pagina
Titolo: | Biology, cultivation and applications of mushrooms / / edited by Arun Arya and Katerina Rusevska |
Pubblicazione: | Singapore : , : Springer, , [2022] |
©2022 | |
Descrizione fisica: | 1 online resource (664 pages) |
Disciplina: | 635.8 |
Soggetto topico: | Mushrooms |
Bolets | |
Fongs | |
Soggetto genere / forma: | Llibres electrònics |
Persona (resp. second.): | AryaArun |
RusevskaKaterina | |
Nota di contenuto: | Intro -- Foreword -- Preface -- Contents -- Editors and Contributors -- Part I: Applications and Cultivation of Mushrooms -- Chapter 1: Beauty, Diversity, and Potential Uses of Certain Macrofungi -- 1.1 Introduction -- 1.1.1 What Are Mushrooms? -- 1.1.2 Stages in Life Cycle of Basidiomycetous Fungi -- 1.2 Diversity and Uses of Certain Macrofungi -- 1.2.1 Agaricus L. -- 1.2.2 Amanita Pers. -- 1.2.3 Bisporella Sacc. -- 1.2.4 Calocybe Kühner ex Donk -- 1.2.5 Calvatia Fr. (Giant Puff ball) -- 1.2.6 Craterellus Sacc -- 1.2.7 Cyathus Haller (Bird´s Nest Fungus) -- 1.2.8 Ganoderma P. Karst. (Reishi Mushroom) -- 1.2.9 Grifola Grey (Maitake Mushroom) -- 1.2.10 Lentinus Fr. (Shiitake) -- 1.2.11 Lenzites Fr. -- 1.2.12 Morchella Dill. ex Pers. -- 1.2.13 Mycena (Pers.) Roussel -- 1.2.14 Phellinus Quel. -- 1.2.15 Pleurotus (Fr.) P. Kumm. (Oyster Mushroom) -- 1.2.16 Russula Pers. -- 1.2.17 Termitomyces R. Heim -- 1.2.18 Tremella Pers. -- 1.3 Medicinal Uses of Macrofungi -- 1.3.1 Isolation and Characterization of Secondary Metabolites -- 1.4 Mcrofungi Used as Nutraceuticals -- 1.5 Other Uses of Macrofungi -- 1.6 Conclusions -- References -- Chapter 2: Therapeutic Potential of Medicinal Mushrooms: Insights into Its Use Against Covid-19 -- 2.1 Introduction -- 2.2 Potential Medicinal Mushrooms and Bioactive Compounds as Treatment For COVID-19 -- 2.2.1 Cordyceps sp. (Caterpillar Fungus) -- 2.2.2 Ganoderma sp. (Lingzhi/Reishi) -- 2.2.3 Inonotus obliquus (Chaga Mushroom) -- 2.2.4 Lentinula edodes (Shiitake Mushroom) -- 2.3 Other Mushrooms with Anti-Viral Activities, Bioactive Compounds and Their Mechanisms of Actions Relevant to COVID-19 -- 2.4 Conclusion -- References -- Chapter 3: Recent Advances in the Discovery of Bioactive Metabolites from Xylaria Hill ex Schrank -- 3.1 Introduction -- 3.2 Bioactive Metabolites -- 3.2.1 Antibacterial Metabolites. |
3.2.2 Antifungal Metabolites -- 3.2.3 Antimicrobial Metabolites -- 3.2.4 Cytotoxic Metabolites -- 3.2.5 Antimicrobial and Cytotoxic Metabolites -- 3.2.6 Anti-inflammatory Metabolites -- 3.2.7 Acetylcholinesterase (AChE) Inhibitors -- 3.2.8 Immunosuppressive Metabolites -- 3.2.9 Metabolites with Antioxidant Activities -- 3.3 Other Bioactive Metabolites -- 3.4 Cultivation Strategies of Xylaria -- 3.5 VOC´s Produced by Xylaria -- 3.6 Conclusions -- References -- Chapter 4: Wild Medical Macrofungi in Montenegro: Diversity, Distribution, Ecology, and Uses -- 4.1 Introduction -- 4.2 The Characteristics of Vegetation of Montenegro -- 4.3 Materials and Methods -- 4.4 The Review of Taxa of Wild Medical Macrofungi in Montenegro with Their Distribution and Ecology -- 4.5 Conclusion -- References -- Chapter 5: Health Promoting and Pharmacological Compounds from Mushrooms -- 5.1 Introduction -- 5.2 Traditional Usage of Mushrooms as Protective and Health Boosting Food -- 5.3 Nutritional and Bioactive Components of Mushrooms -- 5.3.1 Proteins and Amino Acids -- 5.3.2 Carbohydrates and Fiber -- 5.3.3 Lipids -- 5.3.4 Minerals -- 5.3.5 Vitamins -- 5.3.6 Polyphenols Including Flavonoids -- 5.4 Mushrooms as Probiotics -- 5.5 Antiviral Compounds from Mushrooms -- 5.6 Nanoparticles from Mushrooms -- 5.7 Conclusion -- References -- Chapter 6: The Nutritional and Pharmacological Potential of Medicinal Mushroom ``Ganoderma lucidum (Lingzhi or Reishi)´´ -- 6.1 Introduction -- 6.2 History: A Divine Medicinal Mushroom Ganoderma lucidum -- 6.3 Cultivation of Ganoderma lucidum -- 6.4 Chemical Composition and Nutritional Benefits -- 6.5 Products and Formulations Developed from Ganoderma lucidum -- 6.6 Pharmacologically Potential Bioactive Compounds -- 6.6.1 Polysaccharide and Peptidoglycan -- 6.6.2 Triterpenes -- 6.6.3 Other Metabolites. | |
6.7 Therapeutic Properties OF Ganoderma lucidum -- 6.7.1 Immunomodulatory and Anticancer Activity -- 6.7.2 Antioxidant and Anti-inflammatory Activity -- 6.7.3 Antiviral Activity -- 6.7.4 Antimicrobial Activity -- 6.8 Conclusion and Future Prospective Research -- References -- Chapter 7: Anti-Aging Properties of Medicinal Mushrooms in Systemic Aesthetic Medicine -- 7.1 Introduction -- 7.2 Skin Aging -- 7.3 Bioactive Molecules from Fungal Extracts for Cosmetics -- 7.3.1 Terpenes and Terpenoids -- 7.3.2 Selenium -- 7.3.3 Polysaccharides -- 7.4 Cosmeceutics and Nutricosmetics -- 7.4.1 Hydration Effect -- 7.4.2 Anti-Oxidant Activity -- 7.4.3 Anti-Wrinkles Activity -- 7.4.4 Skin Clearance -- 7.5 Conclusions -- References -- Chapter 8: Diversity, Chemistry, and Environmental Contamination of Wild Growing Medicinal Mushroom Species as Sources of Biol... -- 8.1 Introduction -- 8.1.1 Search Strategy -- 8.2 Overview of Bioactive Properties of Medicinal Mushrooms From Serbia and the Balkan Region -- 8.3 Taxonomy of Genera Ganoderma, Coprinus, Pleurotus, Schizophyllum, Trametes, and Hericium -- 8.4 Chemical Characterization and Biological Activity (Antioxidative, Antidiabetic, Ache Inhibitory) -- 8.4.1 Ganoderma lucidum -- 8.4.2 Ganoderma applanatum -- 8.4.3 Ganoderma pfeifferi -- 8.4.4 Ganoderma resinaceum -- 8.4.5 Coprinus comatus -- 8.4.6 Pleurotus ostreatus -- 8.4.7 Schizophyllum commune -- 8.4.8 Trametes versicolor -- 8.4.9 Hericium erinaceus -- 8.4.10 Cosmeceuticals -- 8.5 Environmental Contamination -- 8.5.1 Trace Element Accumulation -- 8.5.2 Radionuclides Accumulation -- 8.6 Conclusion -- References -- Chapter 9: Edible and Medicinal Mushrooms: Some Aspects and Prospects -- 9.1 Introduction -- 9.2 Edible Mushrooms -- 9.2.1 Agaricus L. -- Significance -- Occurrence -- Fruit Body -- 9.2.2 Auricularia Bull. -- Significance -- Occurrence. | |
Fruit Body (Fig. 9.1b) -- 9.2.3 Boletus L. -- Significance -- Occurrence -- Fruit Body -- 9.2.4 Calocybe indica Purkayastha and A. Chandra -- Significance -- Occurrence -- Fruit Body (Fig. 9.1d) -- 9.2.5 Coprinus -- Significance -- Occurrence -- Fruit Body (Fig. 9.2a) -- 9.2.6 Flammulina velutipes (Curtis) Singer -- Significance -- Occurrence -- Fruit Body (Fig. 9.2b) -- 9.2.7 Lentinus edodes (Berk.) Singer -- Significance -- Occurrence -- Fruit Body (Fig. 9.2c) -- 9.2.8 Lycoperdon P. Micheli -- Significance -- Occurrence -- Fruit Body (Fig. 9.2d) -- 9.2.9 Morchella Dill. ex Pers. -- Significance -- Occurrence -- Fruit Body (Fig. 9.2e) -- 9.2.10 Pleurotus (Fr.) P. Kumm. -- Significance -- Occurrence -- Fruit Body (Fig. 9.2f) -- 9.2.11 Termitomyces microcarpus (Berk. and Broome) R. Heim -- Occurrence -- Fruit Body (Fig. 9.2g) -- 9.2.12 Tuber P. Micheli -- Significance -- Occurrence -- Fruit Body (Fig. 9.2h) -- 9.2.13 Volvariella Speg. -- Significance -- Occurrence -- Fruit Body (Fig. 9.2i) -- 9.3 Medicinal Importance of Mushrooms -- 9.3.1 Haematological Effects -- 9.3.2 Antiviral Effects -- 9.3.3 Antitumour Effects -- 9.3.4 Renal and Cardio-Vascular Effects -- 9.3.5 Carcinogenic Effects -- 9.3.6 Hallucinogenicity -- 9.3.7 Allergic Reactions -- 9.4 Other Medicinal Values -- 9.5 Nutritional Value of Mushrooms -- 9.5.1 Protein -- 9.5.2 Fat -- 9.5.3 Carbohydrates -- 9.5.4 Fibre -- 9.5.5 Vitamins -- 9.5.6 Minerals -- 9.5.7 Nucleic Acid Content -- 9.6 Mushroom Cultivation and Its Importance in Economy -- 9.6.1 Cultivation of White Button Mushroom -- Spawn Production -- Grain Spawn (Fig. 9.3a) -- Mushroom Production -- Compost Preparation (Fig. 9.3b) -- Spawning (Fig. 9.3c) -- Casing -- Cropping (Fig. 9.4a) -- Canning (Fig. 9.4b) -- 9.6.2 Brief Account of the Cultivation of Oyster and Paddy Straw Mushroom -- Volvariella -- References. | |
Chapter 10: Truffles: The Cultivation and Health Benefits -- 10.1 Introduction -- 10.2 Truffles and the Environment -- 10.2.1 Truffles: Life Cycle -- 10.3 Cultivation of Truffles -- 10.4 Types, Morphology, and Appropriation -- 10.5 Bioactive Compounds and Truffles -- 10.6 Bioactivities of Truffles -- 10.6.1 Anti-Tumor Efficacy -- 10.6.2 Cancer Prevention Agent and Anti-Inflammatory Exercises -- 10.6.3 Antimicrobial Activity -- 10.6.4 Sexual Enhancer -- 10.7 Other Uses -- 10.7.1 As Food -- 10.7.2 Truffles with Unique Nutritional Value -- 10.7.3 Analysis of Enzyme Changes -- 10.8 Distribution and Development -- 10.8.1 Fame´s Stumbling Blocks -- 10.9 Conclusion and Future Prospects -- References -- Chapter 11: Auricularia spp.: from Farm to Pharmacy -- 11.1 Introduction -- 11.1.1 Ethnobotanical Uses of Auricularia spp. -- 11.1.2 Characters and Uses of Common Species -- 11.1.3 Research on Cultivation, Nutritional and Medicinal Aspects of Auricularia spp. -- 11.2 Cultivation of Auricularia spp. -- 11.2.1 Mycelial Culture -- 11.2.2 Spawn Production -- 11.2.3 Fruit Body Production -- 11.3 Nutritional Composition of Auricularia spp. -- 11.3.1 Moisture -- 11.3.2 Carbohydrate -- 11.3.3 Proteins and Amino Acids -- 11.3.4 Lipids and Fatty Acids -- 11.3.5 Dietary Fiber -- 11.3.6 Ash -- 11.3.7 Vitamins -- 11.4 Medicinal Effects of Auricularia spp. -- 11.4.1 Antioxidant Activity -- 11.4.2 Antimicrobial Activity -- 11.4.3 Cytotoxic, Antitumor, and Anticancer Effect -- 11.4.4 Immune-Modulation Activity -- 11.4.5 Hypolipidemic/Hypocholesterolemic Effect -- 11.4.6 Antidiabetic/Hypoglycemic Effect -- 11.4.7 Hepatoprotective Effect -- 11.4.8 Anticoagulant Activity -- 11.4.9 Anti-Pesticide Effect -- 11.4.10 Other Biological Activity -- 11.5 Conclusion -- References -- Chapter 12: Therapeutic Potential of Mushroom Bioactive Nutraceuticals -- 12.1 Introduction. | |
12.2 Bioactive Molecules from Mushrooms. | |
Titolo autorizzato: | Biology, cultivation and applications of mushrooms |
ISBN: | 981-16-6256-8 |
981-16-6257-6 | |
Formato: | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910743214403321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |